Results 91 to 100 of about 264,442 (390)

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Circulation, 2020
Supplemental Digital Content is available in the text.
Matthew M. Y. Lee, K. Brooksbank, K. Wetherall, K. Mangion, G. Roditi, R. Campbell, C. Berry, Victor Chong, Liz Coyle, K. Docherty, J. Dreisbach, Catherine Labinjoh, N. Lang, V. Lennie, A. McConnachie, C. Murphy, C. Petrie, J. Petrie, Iain A Speirits, S. Sourbron, P. Welsh, R. Woodward, A. Radjenovic, P. Mark, J. McMurray, P. Jhund, M. Petrie, N. Sattar   +27 more
semanticscholar   +1 more source

Guideline‐directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP‐HF registry

European Journal of Heart Failure, 2023
Persistent symptoms despite guideline‐directed medical therapy (GDMT) and poor tolerance of GDMT are hallmarks of patients with advanced heart failure (HF) with reduced ejection fraction (HFrEF). However, real‐world data on GDMT use, dose, and prognostic
D. Tomasoni, M. Pagnesi, G. Colombo, M. Chiarito, D. Stolfo, L. Baldetti, C. Lombardi, M. Adamo, Giuseppe Maggi, R. Inciardi, F. Loiacono, M. Maccallini, A. Villaschi, Gaia Gasparini, Marco Montella, Stefano Contessi, Daniele Cocianni, M. Perotto, G. Barone, M. Merlo, A. Cappelletti, G. Rosano, G. Sinagra, D. Pini, G. Savarese, M. Metra   +25 more
semanticscholar   +1 more source

Electrocatalytic Reduction of CO2 to Ethylene: Catalyst Design and Synchrotron‐Based Characterizations

Advanced Functional Materials, EarlyView.
This review evaluates strategies for electrochemical CO2 reduction to ethylene, focusing on copper‐based catalyst design and microenvironment modulation to achieve industrial‐grade performance. By leveraging operando synchrotron‐based characterizations, we provide a multiscale understanding of dynamic structural transformations and key reaction ...
Meng Zhang, Zuolong Chen, Yimin A. Wu
wiley   +1 more source

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis

Brazilian Journal of Medical and Biological Research
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have symptoms and signs of HF with normal or near-normal left ventricular ejection fraction (LVEF ≥50%).
Chao Ma, Huan Luo, Lei Fan, Xiaoyan Liu, Chengshan Gao   +4 more
doaj   +1 more source

Type of atrial fibrillation and clinical outcomes in patients with heart failure and reduced ejection fraction [PDF]

, 2017
Background: Atrial fibrillation (AF) is common in heart failure (HF), but the outcome by type of AF is largely unknown. Objectives: This study investigated outcomes related to type of AF (paroxysmal, persistent or permanent, or new onset) in 2 ...
Abraham, William T., Desai, Akshay S., Dickstein, Kenneth, Jhund, Pardeep S., Køber, Lars, McMurray, John J.V., Mogensen, Ulrik M., Packer, Milton, Rouleau, Jean L., Solomon, Scott D., Swedberg, Karl, Zile, Michael R.   +11 more
core   +3 more sources

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source

Clinical management of heart failure with improved ejection fraction: treatment and maintenance

Shanghai Jiaotong Daxue xuebao. Yixue ban
In patients with heart failure with reduced ejection fraction (HFrEF), some individuals demonstrate significant improvement in left ventricular ejection fraction (LVEF) during subsequent evaluations after treatment.
XU Tianyun, SHEN Yiming, JIANG Meng
doaj   +1 more source

Myocardial Revascularization in Heart Failure With Reduced Ejection Fraction. [PDF]

Dtsch Arztebl Int
Haring B, Bauersachs J, Frey N, Hoppe UC, Doenst T, Böhm M.   +5 more
europepmc   +2 more sources

Isosorbide dinitrate, with or without hydralazine, does not reduce wave reflections, left ventricular hypertrophy, or myocardial fibrosis in patients with heart failure with preserved ejection fraction [PDF]

, 2017
Background-Wave reflections, which are increased in patients with heart failure with preserved ejection fraction, impair diastolic function and promote pathologic myocardial remodeling.
Akers, Scott, Beraun, Melissa, Chirinos, Julio A., Chittams, Jesse, Haines, Philip G., Koppula, Maheswara R., Rawat, Deepa, Segers, Patrick, Shiva-Kumar, Prithvi, Soto-Calderon, Haideliza, Townsend, Raymond R., Varakantam, Swapna, Witschey, Walter R., Zamani, Payman   +13 more
core   +1 more source

Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial

European Journal of Heart Failure, 2021
Vericiguat reduced the primary composite outcome of cardiovascular death or heart failure (HF) hospitalization in patients with worsening HF with reduced ejection fraction (HFrEF) and a lower limit of baseline estimated glomerular filtration rate (eGFR ...
A. Voors, H. Mulder, E. Reyes, M. Cowie, Johan Lassus, A. Hernandez, J. Ezekowitz, J. Butler, C. O'connor, J. Koglin, Carolyn S. P. Lam, B. Pieske, L. Roessig, P. Ponikowski, K. Anstrom, P. Armstrong   +15 more
semanticscholar   +1 more source